Notes

The subsidiary of YABEN chemical was fined 280000 won for 46 trillion potential safety problems.
NMN (Nicotinamide Mononucleotide),

China Internet Finance July 17 (reporter Li Bingyan, Li Yu) July 15 YABEN chemical (300261). SZ) Nantong YABEN Chemical Co., Ltd. (hereinafter referred to as Nantong YABEN), a wholly-owned subsidiary of the company, issued announcement no. of decision on administrative punishment issued by Nantong Emergency Management Bureau.
Production safety cannot be guaranteed due to safety risks. At that time, Nantong Emergency Management Bureau made an on-site treatment decision and ordered the whole plant of Nantong YABEN to stop production temporarily. According to the previous announcement, Nantong YABEN said that the impact of this production on the company's revenue is about 6% ~ 13% of the total operating revenue in 2019, and the impact on the company's net profit is about 13 million ~ 25 million won.
According to public data, Nantong YABEN was established in 2010 with a registered capital of 604878100 won. The company's main business is the production and sales of agricultural and pharmaceutical intermediates. In 2019, the company realized a profit of 927 million won and a net profit of 88.2316 million won.
Two people were killed and one injured in a burning and explosion accident in Wenya Nantong.
This is not the first time that Nantong YABEN has been concerned about potential safety hazards. In February 2019, a waste water bucket deflagration accident occurred in YABEN, Nantong, resulting in two deaths and one injury.
It is reported that during the trial production of Nantong YABEN, the waste water bucket exploded during waste water cleaning and support installation. The accident exposed problems such as failure to fulfill the main responsibility of enterprise safety production. The briefing added that the protection of the accident site was poor, and the company cleaned up the accident site five hours after the accident.
Affected by the accident, Nantong YABEN stopped production for more than three months, and the production and sales of YABEN chemical decreased in 2019.
The accurate "hot spots" have been investigated by the CSRC.
Ya culture is a company with many "stories". In March 2020, the CSRC filed a case for violation of information disclosure violations such as misleading statements.
Because of the novel coronavirus pneumonia, the company has made a strong demonstration of its "new crown pneumonia epidemic prevention" drugs. Novel coronavirus pneumonia is a company that has been engaged in the business of "new crown pneumonia prevention". However, in the early stage of public communication, it did not show that the proportion of related businesses was small, and had little impact on the company's performance and did not remind the company of the related risks during the continuous rising of the stock. It is reported that before replying to the exchange's concern letter, I received a "misleading statement".
In addition to the hot spots of infectious diseases, recently, with the official launch of the NMN concept of the Chinese version of the elixir of immortality, YABEN chemistry has also fallen into the forefront of the storm.
Homepage: https://www.esthelivsale.com/wholesale